Catalyst Wire Dossier Catalyst Wire Dossier

NOMAC-E2 Combined Oral Contraceptive

nomegestrol acetate and estradiol (17β-estradiol) · Organon
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NOMAC-E2 Combined Oral Contraceptive, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive [Phase 3]

See pricing